Financials

News Discussions Technicals Seasonals

CSWYY fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to China Shineway Pharmaceutical Group Ltd. operating, investing, and financing activities

CSWYY free cash flow for H1 24 is 85.01 M USD. For 2023, CSWYY free cash flow was 119.92 M USD and operating cash flow was 140.29 M USD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: USD

TTM

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—